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                                     INTRODUCTION 
                         Acquired Immunodeficiency Syndrome(AIDS), caused by the Human 
Immunodeficiency Virus(HIV) is a major public health problem  and is a  major killer 
throughout the world. It is the biggest challenge for the medical community to treat and 
effectively cure the disease. The ENT and Head & Neck Surgeons have the main 
responsibility in the earlier recognition of ENT and Head & Neck manifestations of 
HIV infection and to treat accordingly. 
HISTORICAL ASPECTS 
                  Smallpox, a viral disease, once a major killer throughout the world was 
declared eradicated by WHO on 8th May, 1980. The eradication of smallpox is one of 
the most brilliant accomplishments in the medical history in recent times and indeed a 
historical milestone.47  The very next year, in the summer of 1981, a new challenge to 
the medical fraternity, AIDS, was recognized in the United States of America. 
                  It came to recognition by the Centre of Disease Control and 
Prevention(CDC), of U.S., when it reported the unexplained occurrence of 
Pneumocystis carinii pneumonia in 5 previously healthy homosexual men in Los 
Angeles and of Kaposi’s sarcoma in 26 previously healthy homosexual men in New 
York and Los Angeles. Thereafter, it was recognized in Injection Drug Users(IDU), 
recipients of blood transfusion and in hemophiliacs.5 
                In 1983, HIV was isolated from a patient with lymphadenopathy and in 1984, 
it was demonstrated clearly to be the causative agent of AIDS. In 1985, a sensitive 
Enzyme Linked Immunosorbent Assay(ELISA) was developed. When the virus was 
first identified, it was called “Lymphadenopathy-associated virus(LAV)” by the French 
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scientists. Researchers in USA called it “Human T-cell lymphotropic virus III(HTLV-
III)”. In May 1986, the International Committee on the Taxonomy gave it a new name: 
Human Immunodeficiency Virus(HIV).47 
EPIDEMIOLOGY 
               AIDS is  aptly called the modern pandemic. Recognised as an emerging 
disease only in the early 1980s, AIDS has rapidly established itself throughout the 
world. AIDS has evolved from a mysterious illness to a global pandemic which has 
infected tens of millions in less than 20 years. 
WORLD SCENARIO 
 At the end of 2004, 25 million people had already died of AIDS. Counting both 
those who have died and those currently living with the virus, in the past 20 years, 65 
million people have been infected. AIDS had orphaned more than 13 million children 
worldwide. In South and South East Asia and the Pacific, about 6.1 million adults and 
8,00,000 children were newly infected with the adult prevalence of 0.6%. 
 Globally, the total number of persons living with HIV/AIDS is about 39.4 
million and the total number(no.) of persons newly infected with HIV during 2004 is 
about 4.9 million and the no. of  AIDS deaths during 2004 were about 3.1 million. 
INDIAN SCENARIO 
 HIV estimates for the year 2004 have been worked out to be 5.134 million HIV 
infection in the adult population. The cumulative no. of AIDS cases reported as on July 
2005 is 1,11,608, out of which 89% of cases are in the age group of 15 to 44 years, the 
economically productive age group. Out of the total AIDS cases reported 73% are men 
and 27% are women. 
 3                                                                                                                                         
 One of the characteristic features of Indian HIV scenario is its heterogeneousity. 
While the whole country is afflicted with HIV infection, its prevalence varies from 
state-to-state. The  most populous states of India are least affected, for e.g. Uttar 
Pradesh, Bihar, Rajasthan, Madhya Pradesh, Orissa, etc, while states like Maharashtra, 
Tamil Nadu, Karnataka, Andhra Pradesh, Manipur and Nagaland are the most affected. 
In these states HIV infection has even percolated into the general population leading to 
intense mother to child transmission of  HIV. 
TAMILNADU SCENARIO 
As on July 2005 the total no. of AIDS cases is about 52036 in Tamilnadu, which 
is the highest in India. However Antenatal prevalence in Tamilnadu has come down to 
0.63 in 2004 from 1.13 in 2001, while other states like Maharashtra, Karnataka, Andhra 
Pradesh, Manipur, Mizoram, Nagaland and Dader Haveli where the  HIV infection has 
crossed 1%.  In Chennai the Antenatal prevalence was only 0.17 during 2004. The 
epidemic in Tamilnadu has clearly shifted from high-risk groups to general population. 
HIV/AIDS IMPACT 
 1. Effect on population 
                    AIDS deaths in youths and children may reduce expected population 
growth by over 30% and the adult mortality rate may rise up to three times. 
           2. Effect on socio-economic development 
                    HIV/AIDS strikes the economically productive population on whom 
society relies for production and reproduction. So it affects the overall socio-economic 
development of not only a single family but the whole country. 
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 3.Effect on family 
                    As the earning family members die of AIDS, their elderly relatives are left 
without support and their children become orphaned. 
 4.Effect on Medicare 
                     At institutional level, it will result in a high bed occupancy & medicare 
cost. At general practitioner level, it will mean larger proportion of HIV/AIDS cases 
than in routine practice and need for routine universal precautions. 
 
DEFINITION 
 The case definition of AIDS has undergone several revisions over the years and 
the latest revision took place in 1993. This revised CDC classification system for HIV 
infected adolescents and adults categorizes persons on the basis of clinical conditions 
associated with HIV infection and CD4+ T lymphocyte counts. The system is based on 
3 ranges of CD4+ T lymphocyte counts and 3 clinical categories and is represented by a 
matrix of 9 mutually exclusive categories. Using this system, any HIV-infected 
individual with a CD4+T cell count of < 200/L has AIDS, by definition, regardless of 
the presence of symptoms or opportunistic diseases. 
 While the definition of AIDS  is complex and comprehensive, the clinician 
should not focus on whether AIDS is present but should view HIV disease as a 
spectrum ranging from primary infection, with or without the acute syndrome, to the 
asymptomatic state, to advanced disease. The definition of AIDS was established not 
for the practical care of the patients but for surveillance purposes.5 
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                Clinical categories 
 
CD4+cell 
Categories 
          A 
Asymptomatic,  
Acute (primary) 
HIV or PGL 
               B 
Symptomatic, 
 Not A or C conditions 
 
AIDS-related 
Conditions 
 
>500L 
 
A1 
 
B1 
 
C1 
 
200-499L 
 
A2 
 
B2 
 
C2 
 
<200L 
 
A3 
 
B3 
 
C3 
 
CLINICAL CATEGORIES OF INFECTION: 
Category A: 
Consists of one or more of the conditions below in an adolescent or adult>13 years 
with documented HIV infection, conditions listed in categories B and C must not have 
occurred. 
1. asymptomatic HIV infection. 
2. persistent generalized lymphadenopathy. 
3. acute(primary) HIV infection with accompanying illness or H/O acute HIV 
infection. 
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Category B: 
Consists of symptomatic conditions in an HIV infected adolescent or adult that are not 
included among conditions listed in clinical category C and that meet atleast one of the 
following criteria: 
1. the conditions are attributed to HIV infection or are indicative of defect in cell-
mediated immunity or 
2. the conditions are considered by physicians to have a clinical course or to 
require management that is complicated by HIV  infection. 
Examples include, but not limited to, the following: 
1. Bacillary angiomatosis. 
2. candidiasis, oropharyngeal. 
3. candidiasis, vulvovaginal, persistent, frequent, or poorly responsive to 
therapy. 
4. cervical dysplasia(moderate or severe)/cervical carcinoma in situ. 
5. constitutional symptoms, such as fever(38.5°C) or diarrhea lasting >1month. 
6. Oral hairy leukoplakia. 
7. herpes zoster involving atleast 2 distinct episodes or more than 1 dermatome. 
8. idiopathic thrombocytopenic purpura. 
9. listeriosis. 
10. pelvic inflammatory disease, particularly if complicated by tubo-ovarian 
abscess. 
11. peripheral neuropathy. 
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Category C: 
Conditions listed in the AIDS surveillance case definition 
1. candidiasis of bronchi, trachea or lungs. 
2. oesophageal candidiasis. 
3. invasive cervical cancer. 
4. coccidioidomycosis, disseminated or extra-pulmonary. 
5. cryptococcosis,extra-pulmonary. 
6. cryptosporidiosis, chronic intestinal(>1month duration). 
7. cytomegalovirus disease(other than liver, spleen or nodes). 
8. cytomegalovirus retinitis(with loss of vision). 
9. encephalopathy, HIV related. 
10. herpes simplex, chronic ulcer (>1month duration); or bronchitis, pneumonia, 
or oesophagus. 
11. histoplasmosis, disseminated or extra-pulmonary. 
12. isosporidiosis, chronic intestinal (>1month duration). 
13. kaposi’s sarcoma. 
14. lymphoma, Burkitts. 
15. lymphoma, primary, of brain. 
16. mycobacterium avium complex or M. kansasii, disseminated or extra-
pulmonary. 
17. mycobacterium tuberculosis, any site pulmonary or extra-pulmonary. 
18. mycobacterium, other species or unidentified species, disseminated or 
extrapulmonary. 
19. Pneumocystis carinii pneumonia. 
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20. pneumonia, recurrent. 
21. Progressive multifocal leukoencephalopathy. 
22. Salmonella septicemia, recurrent. 
23. Toxoplasmosis of brain. 
24. wasting syndrome due to HIV. 
HUMAN IMMUNODEFICIENCY VIRUS 
 The etiologic agent of AIDS is HIV, which is an RNA virus, which belongs to 
the family of human retroviruses(Retroviridae) and the subfamily of lentiviruses. The 
four recognized human retroviruses belong to two distinct groups: the human T 
lymphotropic viruses HTLV-I and HTLV-II, which are transforming retroviruses and 
the human immunodeficiency viruses, HIV-I and HIV-II, which are cytopathic viruses. 
The most common cause of HIV disease throughout the world is HIV-I. HIV-II was 
first identified in 1986 in West African patients and was originally confined to West 
Africa. Both types are prevalent in India, Type I is more frequently reported. HIV I is a 
more virulent pathogen than type II. HIV II is generally milder, slower to progress and 
poorly transmitted vertically. Virus is found in almost all body fluids and organs. But 
they are present in very large numbers in semen, vaginal and cervical secretions and 
blood. The central nervous system, testes, lymph nodes act as reservoirs of HIV. The 
highest concentration of HIV among the bodyfluids is found in cerebrospinal fluid. 
 Electron microscopy shows that the HIV virion is an icosahedral structure 
containing numerous external spikes formed by the two major envelope proteins, the 
external gp 120 and the transmembrane gp 41.  The virion buds from the surfaces of the 
infected cell and incorporates a variety of host proteins including MHC class I and II 
antigens into its lipid layer. 
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 There are two groups of HIV I group M(major) which is responsible for most of 
the infections in the world, and group O(Outlier), a relatively rare viral form found at 
this time in Cameron, Gabon and France. The M group comprises atleast eight sequence 
subtypes or clades designated A through H. subtype A viruses appear to be the most 
common form worldwide. The predominant subtype in Europe and America is subtype 
B. In Africa, more than 75% of strains recovered to date have been of subtypes A,C and 
D. In Asia, HIV I isolated of subtypes E,C and B are found, subtype E accounts for 
most infections in South East Asia, while subtype C is prevalent in India.5 
HOST FACTORS 
AGE AND SEX 
 The Spread of HIV infection occurs most frequently in the sexually active and 
economically productive age group of 15 to 44 years. Globally during 2004 the male to 
female ratio is nearing equal. In India, however, the male to female ratio is 3:1. But in 
Tamilnadu during 1998, NACO(National AIDS Control Organisation) study shows the 
HIV infected cases between males and females to be equal. 
FACTORS INVOLVED IN THE RISK OF ACQUISITION OF INFECTION 
1. No. of sexual partners. 
2. frequency of “at risk” sexual exposures. 
3. local HIV prevalence rates among core groups and bride population, etc. 
4. consistent use of condoms. 
5. presence of sexually transmitted diseases(STD) in any of the partners. 
TRANSMISSION ROUTES 
1. Sexual intercourse (heterosexual or homosexual), when one of the partners is 
infected. 
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2. transfusion of infected blood. 
3. use of contaminated needles/syringes. 
4. from an infected mother to her baby. 
 
 
S.No. 
 
Modes of transmission 
 
Efficacy 
 
Source of infection 
 
1 
 
Sexual intercourse 
 
0.1-1.0% 
 
80-86% 
 
2 
 
Blood transfusion 
 
90-95% 
 
3-5% 
 
3 
 
Perinatal 
 
20-40% 
 
2-3% 
 
4 
 
Injecting Drug use 
 
0.5-1.0% 
 
3-5% 
 
5 
 
Needle stick exposure 
 
< 0.01% 
 
Unknown 
 
PATHOGENESIS 
The natural history of HIV infection begins as soon as the virus enters the 
body of a susceptible host through any of the routes of transmission as discussed 
earlier.  
 HIV infects predominantly T Helper (CD4) lymphocytes. 
 As the numbers and functions of CD4 cells decline, immune deficiency 
sets in. 
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 As immunodeficiency progresses, the subject develops 
secondary(opportunistic) infections and malignancies and further 
constitutional signs and symptoms of the diseases contracted. 
 5-10% of HIV individuals are long term non-progressors and live for 
more than 10 years. 
SEROCONVERSION 
 HIV infection results in a chronic, progressive illness. Its course is marked by 
increasing levels of viral replication and the emergence of more virulent viral strains. 
This process causes the destruction of the immune system. HIV infection is staged by 
CD4 cell counts and clinical symptoms. Not all people progress through all stages and 
the time frames may also vary greatly from person to person. 
WHO CLINICAL STAGING FOR HIV INFECTION 
Clinical group 1 
1. acute HIV infection. 
2. Persistent generalized lymphadenopathy(PGL). 
3. asymptomatic. 
4. normal activity. 
Clinical group 2(Early stage disease) 
1. weight loss less than 10%. 
2. mucocutaneous problems. 
3. herpes zoster. 
4. recurrent URI(upper respiratory infection). 
5. normal activity. 
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Clinical group 3(intermediate stage disease) 
1. weight loss >10%. 
2. chronic diarrhea. 
3. prolonged fever >1 month. 
4.  oral candidiasis. 
5. oral hairy leukoplakia. 
6. pulmonary tuberculosis. 
7. severe bacterial infections. 
8. bed ridden < 50% of the day (previous month). 
Clinical group 4(last stage of disease) 
1. definitive or presumptive diagnosis of any AIDS. 
2. Bed ridden > 50 % of day(previous month). 
 
DISEASE PROGRESSION AND SURVIVAL 
 Disease progression and survival with HIV infection is variable at the individual 
level such as rapid, slow and non progressors. Disease can be rapidly progressive over 
about 2 years or hardly progress at all over 15 years. Disease progression in the initial 
stage proceeds at the same rate for everyone. The available data suggest that 
progression is not affected by race, ethnic background or gender. Older age and lower 
socio-economic status does however adversely affect survival. 
DEATH 
 An individual progress through the various stages of HIV infection at a variable 
rate. In areas where there are inadequate resources for clinical care, people with HIV 
infection can die early due to other conditions even before AIDS develops. Greater 
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exposure to virulent and opportunistic infections accompanied by poor and inadequate 
health care are probably the main reason for this early death. 
DIAGNOSIS 
 HIV infection is diagnosed by blood tests that detect HIV antibodies. HIV 
antibody tests usually done are:  
1. RAPID test 
2. ELISA test 
3. Western blot test 
RAPID and ELISA tests are sensitive, specific and less expensive. These tests 
are commonly used for screening purposes at blood banks and at voluntary 
counseling and testing centres(VCTC) for diagnostic purposes. For diagnostic 
purpose, 2 or 3 consecutive RAPID/ELISA tests have to be carried out, as the 
situation warrants. 
Western blot test, though more specific, is costly. Confirmation can also be done 
by using results from 2/3 consecutive ELISA tests from different kits. 
Diagnosis can also be made by testing for HIV antigens through the following 
tests:   1. Polymerase chain reaction(PCR)                     becoming positive           
           2.Viral load assessment tests                                after 72 hours of                                 
                                                                                                               infection 
4. p24 antigen test, becoming positive after 2 weeks of infection 
 
PREVENTION OF HIV TRANSMISSION 
 By observing the following 
• Abstaining from sex, pre-marital or extramarital. 
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• Being faithful to sexual partner. 
• Using condoms. 
• Practicing safe sex by not exposing a partner or oneself to body fluids 
such as semen and vaginal secretions. 
 
 Not sharing needles, syringes or other skin piercing equipments with others 
since they may be contaminated with infected blood. 
 Not reusing needles and syringes in health care settings before autoclaving them. 
 Screening blood and blood products for HIV. 
 Autologous blood transfusion. 
 
OTORHINOLARYNGOLOGIC (ENT) AND HEAD & NECK 
MANIFESTATIONS 
 It is very important for ENT & Head and Neck surgeon to recognize early and 
late lesions of HIV infection so that these patients are diagnosed early and receive 
appropriate care. 
It was reported initially that 41 percent of patients with AIDS had head and neck 
manifestations. As awareness has increased, however, recognition of these lesions has 
also increased, until now, it seems that nearly 100 percent of patients with AIDS have 
head and neck manifestations. The primary care physician and the otolaryngologist play 
pivotal roles in both diagnosis and management of these conditions. It is of utmost 
importance that clinicians recognize these manifestations at an early stage, so that 
prompt treatment can be undertaken. 
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AIDS defining ENT manifestations: 
1. chronic/recurrent Oropharyngeal Candidiasis. 
2. chronic recurrent mucocutaneous Herpes simplex. 
3. Oral hairy leukoplakia. 
4. Oral/aural Kaposi’s sarcoma. 
Of these Oral hairy leukoplakia is virtually pathognomonic of HIV disease.1 
 Though kaposi’s sarcoma is rare in our country, it is an AIDS defining illness  
and  we should suspect HIV infection in those individuals with kaposi’s sarcoma. It  
is very common in African homosexual men. 
Other ENT  manifestations common in HIV/AIDS mentioned below in the table.11 
Head and Neck Manifestations of AIDS/HIV 
Otologic  
• Otitis 
externa  
• Serous otitis 
media  
• Kaposi's 
sarcoma  
• Eustachian 
tube 
dysfunction  
and 
Sensorineural 
hearing loss 
Nasal and sinus  
• Cutaneous  
o Kaposi's 
sarcoma  
o Herpes 
simplex ulcers  
o Herpes zoster  
• Noncutaneous  
o Adenoid 
hypertrophy  
o Eustachian 
tube 
obstruction  
Oral  
• Recurrent 
aphthous 
ulcers  
Condyloma  
• Candidiasis  
• Hairy 
leukoplakia  
• Herpes 
simplex  
• Gingivitis  
Stomatitis  
• Periodontitis  
Neck  
• Generalized 
lymphadenopathy  
• Neck mass (due to 
infection with 
Mycobacterium 
tuberculosis, 
Mycobacterium avium 
complex, 
cryptococcosis, 
histoplasmosis or 
coccidioidomycosis)   
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Nose: 
Acute/chronic sinusitis 
Throat: 
• Kaposi's 
sarcoma  
• Non-
Hodgkin's 
lymphoma 
and 
Squamous cell 
carcinoma 
 Tuberculous 
laryngitis 
Gingival 
granuloma,cyst 
 
• Neck: 
Parotid gland cyst 
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                    REVIEW OF LITERATURE 
 
Barzan L & Tavio M. et al made  ENT evaluation of  210 HIV  positive  
patients without symptoms related selection.  The majority of them were men and 
intravenous drug users. The frequency of enlarged neck nodes, neck mass, 
nasopharyngeal lymphatic tissue hypertrophy, extranodal localization of non-Hodgkin's 
lymphomas, Kaposi's sarcoma, oral hairy leukoplakia, candidiasis and other less 
common findings was  reported, in relation to the stage of the disease. Overall 84 per 
cent of the observed patients had head and neck manifestations. An ENT evaluation in 
every HIV infected patient was suggested. 
  Deb T& Singh NB et al2  made  a preliminary, prospective study, conducted in 
the department of ENT and microbiology, Regional Institute of Medical Sciences, 
Imphal, Manipur. The clinical presentations for HIV infection and AIDS with head and 
neck involvement were shown. Forty patients with HIV infection and various head and 
neck manifestations were included in this study The median age of diagnosis was 33 
years with male to female ratio of 3.4: 1. The predominant mode of transmission of HIV 
infection among the patients of this series was found to be intravenous drug use (IDU) 
in 65% of cases. Rhinosinusitis was found to be the most common presenting feature 
constituting 27.5% of the cases followed by oral candidiasis in 22.5% of the cases. 
After consideration and observation of all the facts and findings, their study concluded 
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and proposed that it will be well for all clinicians, including otolaryngologists especially, 
to bear a high level of suspicion for HIV infections in their day to day practice. 
Birchall MA& Horner PD et al  identified how the spectrum of head and neck 
complications of HIV disease had altered over the 7-year period between 1984 and 
1991, a prospective collection of data on 429 HIV-positive subjects referred since 1984 
was undertaken. Information was grouped into three study periods by date of 
presentation for analysis of trends. There has been a trend towards increased 
heterosexual acquisition (P < 0.02) and a decrease over time in the proportion of 
patients presenting with AIDS, as a proportion of HIV-positive patients (20/31 1983-
1984; 90/179 1989-1991: P < 0.001). While the occurrence of mucosal candidiasis (P  
< 0.0001) and Kaposi's sarcoma (P < 0.05) has decreased that of rhinosinusitis (P < 
0.0001) and non-Hodgkin's lymphoma (P < 0.05) has increased. Cervical 
lymphadenopathy has shown a significant decline (P < 0.05), but other conditions have 
been relatively constant. Otolaryngologists should be aware of current emphasis in the 
head and neck manifestations of HIV infection, which have important implications for 
diagnosis and management. 
          According to Helsper J& Formenti S et al  the initial manifestation of AIDS in 
the head and neck region occurs frequently. The purpose of their report had been to alert 
the head and neck surgeon to the occurrence of AIDS-related lesions, their clinical 
characteristics, and disease outcome. Incomplete recognition of these disorders may 
delay appropriate diagnostic study and initiation of therapy. They have described 10 
patients in whom the initial manifestation of AIDS-related malignancies occurred in the 
head and neck region. Six of these patients were found to have Kaposi's sarcoma, 
whereas four had non-Hodgkin's lymphomas. The specific clinical and pathologic 
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aspects of the disease had been described, which represented common patterns of 
presentation. It was crucial to obtain an accurate social history, as well as a complete 
medical history from any patient suspected of having AIDS, and prompt biopsy of 
suspect lesions should be performed. 
                   According to Epstein JB et al the immunosuppressed persons were at 
greater risk of developing malignancies. In human immunodeficiency virus (HIV) 
immunosuppression the most common oral cancers were Kaposi's sarcoma and non-
Hodgkin's lymphoma. Squamous cell carcinoma had also been reported to be associated 
with HIV disease. Kaposi's sarcoma was the most frequent neoplastic disease in 
acquired immunodeficiency syndrome and was by far the most common in the head and 
neck area. They reviewed the prevalence, clinical features, and management of these 
diseases in HIV infection. 
Herdman RC& Forster S et al4  studied 219 patients between October 1984 
and December 1987, who fulfilled the criteria for Acquired Immune Deficiency 
Syndrome (AIDS), as set out by the Centers for Disease Control, Georgia and were seen 
at St. Mary's Hospital, London. The most common otolaryngological manifestations of 
the disease in these patients were oral candidiasis (60%), oesophageal candidiasis (16%), 
persistent generalized lymphadenopathy (27%) and Kaposi's sarcoma (26%).  
             According to Riederer A & Bujia J et al6  the patients with human 
immunodeficiency virus (HIV) infection often present signs and symptoms referable to 
the head and neck. They reviewed the clinical histories of 110 HIV-positive patients 
who presented head and neck manifestations. 48 (43.6%) had head and neck signs 
and/or symptoms as initial manifestation of the syndrome. 40 (36.3%) had oral 
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candidiasis,  18(16.36%) Kaposi's sarcoma, 11 (10%) herpes, 5 (4.5%) hairy 
leucoplakia and 4 (3.6%) lymphoma. 
              According to Ondzotto G& Ibara JR et al7  in human immunodeficiency 
virus infection as well as in related syndromes, cervico-facial and otorhino-laryngologic 
manifestations are current. A retrospective study in Oto-Rhino-Laryngology service of 
Brazzaville University Hospital from December 1995 to November 2001 had been 
reported. 253 patients were selected from a total of 1352 consultations. The study 
population was young (average age: 34 +/- 4.8 years), and most of the patients were 30 
to 49 years old (75.9%). Men represent 51% and women 49%. Although sexual 
multipartnership (59.7%) was the main risk factor, traditional practices (22.8%) were 
not neglictible in Africa. Among all cases, human immunodeficiency virus type 1 was 
found in 72.3% of cases. The affections were located in the neck (40.5%), ear (24.9%), 
pharynx (17.3%), rhinosinus (13.3%), oral cavity and vestibule (2.7%) and larynx 
(1.3%). These main affections were represented by: parotidosis (20.1%), peripheric 
facial paralysis (15.4%), pharyngeal candidiasis (14.6%), sinusitis (14.2%) and 
tuberculous laryngitis (11.5%). Lymphoma (7 cases), kaposi's sarcoma (7 cases) and 
epidermoid carcinoma (1 case) were the malignant affections identified in 15 cases 
(6%). The diagnosis of some affections like cystic parotiditis (11%). African 
histoplasmosis (0.4%) and rhinoscleroma (0.4%) constituted their study particularity. 
The Oto-rhino-laryngologist's role is important in early diagnosis of HIV infection as 
well as in the followed-up of patients. 
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                                    AIM OF THE STUDY 
 
 
 
1. To find out the ENT manifestations in a selected regional population of 50 HIV 
infected patients. 
2. To identify the commoner ENT manifestations in them. 
3. To make these commoner ENT manifestations, a guide for regional ENT 
surgeons, to diagnose HIV/AIDS patients early and to treat them accordingly.  
 
. 
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                        MATERIALS AND METHODS 
  
 The study was conducted after institutional approval. Oral and written consent 
was obtained from all the subjects enrolled in the study. 
STUDY DESIGN 
 This study comprises of, evaluation of the prevalence of ENT manifestations, 
among HIV seropositive patients. It includes selection of 50 HIV seropositive patients 
among the patients attending the Outpatient department of the Upgraded Instittute of 
Otorhinolaryngology(UIORL) and Anti-Retroviral Theray(ART) centre in Government 
General Hospital, Chennai and detailed ENT clinical examination as well as laboratory 
investigations were carried out to evaluate the nature of  ENT presentations of HIV 
infection. It is a prospective study. 
STUDY PERIOD 
  October 2004 to March 2006.  
CRITERIA FOR PATIENT SELECTION 
 The patients were selected according to the criteria given below: 
INCLUSION CRITERIA 
Previously proved seropositive HIV infected patients of age group 20-50 years of 
both sexes with some form of ENT symptoms like 
1. Oral white patches. 
2. Painful Oral ulcers. 
3. Neck swelling. 
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4. Headache. 
5. Nasal obstruction. 
6. Nasal discharge. 
7. Hard of hearing. 
8. Ear discharge. 
9. Ear pain. 
10. Hoarseness of voice/Dysphonia 
11. Throat pain. 
12. Difficulty in swallowing. 
13. Swelling inside  the mouth. 
EXCLUSION CRITERIA 
1. HIV infected patients with no obvious ENT symptoms. 
2. HIV infected patients with coexisting Diabetes Mellitus. 
3. HIV infected patients received/receiving steroids or any other 
immunosuppressive therapy. 
4. HIV infected patients with past history of  hard of hearing and those patients 
who were previously diagnosed to have chronic suppurative otitis media and 
chronic sinusitis. 
     Detailed history was taken and physical examination done for each patient as 
shown in proforma. Selected patients underwent Diagnostic Nasal Endoscopic 
examination and Videolaryngoscopic examination. 
     All patients underwent the following investigations: 
BLOOD TC,DC,ESR,Hb, 
Chest X Ray PA view, 
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 ELISA for HIV, CD4+ T cell count. 
 Selected patients underwent the following investigations: 
1. Gram stain for Oral candidiasis. 
2. Biopsy for histopathological examination for oral hairy leukoplakia. 
3. Tzanck smear for Oral Herpes simplex lesions. 
4. Fine Needle Aspiration Cytology for Neck nodes. 
5. Biopsy for histopathological examination for swelling in oral cavity and 
for suspected Tuberculous laryngitis. 
6. Pure Tone Audiogram for patients with hard of hearing. 
7. Pus for culture and sensitivity (C/S) from pus in ear, middle meatus or 
nasal cavity through DNE. 
8. Sputum AFB for suspected Tuberculous laryngitis. 
CLINICAL EXAMINATION 
 It was done as mentioned in the proforma with special attention to the following: 
1. For oral white patches with suspicion of Oral candidiasis the patches were tried 
to peel off. It exposed a bleeding red raw surface which is indicative of 
candidiasis and if it could not be peeled, oral hairy leukoplakia was suspected 
and the lesion biopsied for histopathological examination. 
2. For multiple painful oral ulcers with suspicion of Oral Herpes simplex, Tzanck 
smear was done to see multinucleated cells with intranulcear inclusion bodies. 
3. Diagnostic Nasal Endoscopic examination(DNE) was done for patients with 
headache, nasal obstruction, postnasal drip and nasal discharge . 
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4. Videolaryngoscopic examination was done for patients with hoarseness of voice, 
throat pain, difficulty in swallowing and who did not co-operate for Indirect 
Laryngoscopic examination. 
 
 DIAGNOSTIC NASAL ENDOSCOPY 
 It was done with a 30°rigid nasal endoscope after proper sterilization with 
Glutaraldehyde(cidex), connected to a cold light source and the following structures 
were examined in detail for pus, polyps, swelling in nasopharynx, medialised uncinate 
process, accessory ostium, prominent bulla, concha bullosa, prominent agger nasi, 
paradoxical middle turbinate with the patient in supine position after adequate local 
anaesthetization and decongestion of nasal mucosa using 4% Lignocaine and 
Oxymetazoline nasal pack: 
Inferior meatus , Inferior turbinate, middle meatus, middle turbinate and nasopharynx. 
Patients with positive findings of chronic sinusitis underwent CT PNS(paranasal 
sinuses), both Axial and Coronal views in bone window setting. 
VIDEOLARYNGOSCOPY 
 For patients who did not co-operate for Indirect Laryngoscopic examination 
even after throat spray with 4% Lignocaine and for patients with doubtful findings on 
indirect laryngoscopy, videolaryngoscopy was done using a 30°rigid endoscope, 
connected to a cold light source, with the patient in sitting position after adequate local 
anaesthetization of throat with 4% Lignocaine spray. Findings noted. 
TUNING FORK TESTS: 
 Tuning Fork Tests were done for patients with hard of hearing. 
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A) Rinne test: 
A 512 Hz tuning fork was gently struck on its prongs and the base of the 
vibrating tuning fork was placed firmly on the mastoid process. The patient was asked 
to indicate by raising his finger as soon as the sound disappears ( Bone conduction 
threshold, BC ). Then the tunning fork was quickly placed, vertically in erect position 2 
cm from the test ear in the line of axis of the external auditory meatus and the test is 
Rinne positive i.e. normal if the patient still heard the sound ( air conduction, AC )  
B) Weber test : 
The base of the  vibrating tunning fork was placed over the skull in the midline 
over the vertex or the glabella and the patient was asked to say in which ear he heard the 
sound better. When the sound was heard better in one ear, that was called lateralization 
of sound to that ear.  
C)Absolute Bone Conduction Test: 
 Bone conduction is a measure of cochlear function. Here the bone conduction of 
the patient and the examiner were compared presuming the examiner has a normal 
cochlear function. A 512 Hz tuning fork was gently struck on its prongs and the base of 
the vibrating tining fork was placed firmly on the mastoid process of the patient and 
shifted  to the mastoid process of the examiner as soon as the patient stops hearing. If 
the examiner still hears then the absolute conduction is reduced(R) for the patient. If the 
examiner also does not hear then the absolute conduction is not reduced(NR). If it is 
reduced then it is inferred that the patient has sensorineural hearing loss. 
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INVESTIGATIONS 
Gram stain for oral candidiasis 
                          For suspected lesions of Oral candidiasis, smear taken from lesions and 
subjected to gram stain. Gram stain was done as follows; 
1. Primary staining with a pararosaniline dye such as  gentian violet 
2. Application of dilute solution of iodine 
3. Decolourisation with an organic solvent such as ethanol 
4. Counterstaining with a dye of contrasting colour such as carbol fuchsin. 
Gram stain shows budding Gram positive cells. Demonstration of mycelial 
forms indicates colonization and tissue invasion and is, therefore, of greater 
significance. 
Tzanck smear for Oral Herpes simplex: 
Tzanck smear is a rapid, fairly sensitive and inexpensive diagnostic 
method. Smears are prepared from suspected  Herpes simplex lesions of 
multiple painful oral ulcers preferably from the base of the vesicles/ulcers and 
stained with 1% aqueous solution of toluidine blue’O’ for 15 seconds. 
Multinucleated giant cells with faceted nuclei and homogenously stained ground 
glass chromatin(Tzanck cells) constitute a positive smear. 
Pure Tone Audiometry: 
 This test was used for measuring hearing acuity. 
           The patient was described what will happen during the test and the purpose of 
the test. Biological calibration was done everyday before starting the test. Both air and 
bone conduction were tested for each ear. 
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Pure Tone Audiometry : Air Conduction Threshold 
 This test was based on the measurement of hearing thresholds for a range of 
puretones presented through earphones according to the ascending method ( Hughson – 
Westlake, up 5, down 10,method ). 
Purpose 
 Pure Tone Audiometry is the most routine audiometric evaluations and the 
resulting pure tone audiogram is widely used as a basic description of the degree of 
hearing loss. 
Procedure 
Test frequencies 
  250, 500, 1000, 2000, 4000, 6000,8000 Hz. The sequence from 1000 Hz 
upwards and then downwards in frequency must be observed.  
Instruction to the patient 
 The patient was instructed that 
- he would hear tones of short duration in either the left or the right ear to 
start with 
- the tones might become very faint 
- he was expected to signal by raising his finger corresponding to the side 
of the ear, as soon as the tone was heard and keep it raised as long as it is 
heard, no matter how faint it was. 
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Threshold determination  
1. The test was started at 1000 Hz. 
2.  A clearly audible signal, about 40 dB HL was presented if the hearing 
threshold of the subject was assumed to be normal and if there was 
difficulty in hearing, 60 dB HLwas given. 
3.  The level of the tone was then reduced in steps of 10 dB until the tone 
became inaudible and the patient did not respond. 
4. Then the level of the tone was increased in steps of 5 dB, presenting one 
pulse at each level until a response was obtained. The level at which the 
subject gave a response after the raise of 5 dB was the threshold. 
5.  Then the test  was continued at the next higher frequency till 8000 Hz. 
6. Again returned to 1000 hz and then tested at 500 Hz and 250Hz. 
7.  The other ear was tested  in the same way, following steps 1 to 7. 
Marking                                            
  Threshold 
Right ear                                
Left ear   
 
 If the same threshold level was obtained for both ears at a certain frequency, the 
symbols were drawn on top of each other. 
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Pure Tone Audiometry : Bone Conduction Threshold 
 This test consists of the measurement of hearing thresholds for pure tones 
presented by means of a bone vibrator placed on the mastoid process behind the outer 
ear. The measurement was performed according to the ascending method ( Hughson 
Westlake, up 5, down 10,method ). 
Purpose 
 Pure tone bone conduction audiometry is a complement to air conduction 
audiometry and provides information about the conductive element of hearing loss. 
Procedure 
Test frequencies 
 250, 500, 1000, 2000, 4000, 6000, 8000 Hz. 
 Instruction to the patient 
 The patient was instructed that 
- he would hear short tones. 
- the tones might be very faint and might be heard in either ear or 
both ears simultaneously 
- he should raise the finger corresponding to the side of the ear, as 
soon as the tone was heard. 
- he should not touch the bone vibrator after its final placement. 
Threshold determination 
1. The test was started with the best ear if the side difference was known or 
with that ear to which the test tones were lateralized in Weber’s test. The 
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bone vibrator was placed over the mastoid process. The test was started 
with 1000 Hz.  A continuous, clearly audible tone was switched on and  
the position of the bone vibrator was adjusted until the patient indicated 
when the tone was loudest. Any contact between the vibrator and the 
outer ear was avoided. The patient should not wear earphone during the 
test. 
2. A test tone of 1 to 2 seconds duration was presented at about 40 dB HL and 
if the level was inaudible, the test tone was increased in steps of 10 dB 
until a response was obtained. 
3. Then the level was reduced in steps of 20 dB, until the tone was inaudible 
and the patient did not respond. 
4.  The level was then increased in steps of 5 dB , until a response was obtained. 
This level at which he responded was the threshold. 
5. Then the test was continued with other test frequencies and the other ear. 
Marking 
                                              Hearing threshold 
 Right side   <– – – <– – – 
 Left side   – – > – – –> 
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Fine Needle Aspiration Cytology 
      It was done for neck mass ie. Cervical lymphadenopathy. It was done using 25 
gauge needle and using left thumb, forefinger and middle fingers the mass was fixed 
and the needle with 2ml.syringe inserted with persistent negative pressure inside the 
mass using the right hand and aspirations done in multiple directions without 
withdrawing the needle out. The aspirate was made into a smear and cytological 
examination done of the stained smear. In experienced hands, it is an extremely 
reliable, rapid and useful technique. In general, negative aspiration cytology is not 
sufficiently reliable and should be ignored. 
Biopsy 
        For swelling inside oral cavity for suspected Kaposi’s sarcoma biopsy taken 
from the lesion under local anaesthesia and sent for histopathological examination in a 
formalin bottle. 
       For suspected tuberculous laryngitis, biopsy taken under local anaesthesia 
using 30°rigid endoscope and Giraffe forceps and sent for histopathological 
examination in a formalin bottle. 
For suspected oral hairy leukoplakia lesions, biopsy taken under local 
anaesthesia and sent for histopathological examination in a formalin bottle. 
Pus for culture and sensitivity 
  Pus was taken from ear and sent for culture and sensitivity and results obtained. 
In nose, using DNE, pus was taken and sent for culture and sensititvity. 
Sputum AFB(Acid Fast Bacilli) 
         For suspected tuberculous laryngitis patients, sputum was collected in sterile 
sputum cups on 3 consecutive days and stained with Ziehl-Neelsen technique(carbol 
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fuschin, Leoffler’s methylene blue) and slides were screened for the presence of acid 
fast bacilli. 
ELISA AND RAPID TESTS 
 This study was conducted in previously seropositive HIV infected patients who 
had underwent ELISA (Enzyme Linked Immunosorbent Assay) or RAPID  test 
accordingly, as per the WHO strategies after appropriate counselling by the Voluntary 
Counselling and Testing Centre(VCTC). 
ELISA TEST 
  The most popular ELISA  involves an indirect method in which antibodies in the 
serum of the patients are allowed to react with HIV antigen attached to a well of a 
96 well microtitre plate or to a macroscopic beed that subsequently is placed in a 
plate well. The test kits used in the study are LABSYSTEMS  and DETECT-HIV. 
    RAPID TEST 
This can be performed in less than 30 minutes. When performed 
correctly rapid HIV assays are accurate. They are easy to perform and have 
utility in developing countries where facilities may not be optimal, stable 
electricity may be unavailable and formal educational programmes for 
laboratorians are absent. They produce a well circumscribed coloured dot on the 
solid phase surface if the test is positive. The test kits used in the study are 
TRIDOT and IMMUNOCOMB (BISPOT) where both HIV I and HIV II can be 
detected.  
CD4+ T cell count 
Also CD4+ T cell count was done for all patients as a routine in the ART 
centre. Normal CD4 cell count is 600-1500 cells/cu.mm. 
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Finally the diagnosis was made using detailed history, detailed physical 
examination and investigations. 
 
 
UNIVERSAL BARRIER PRECAUTIONS 
 A set of precautionary measures to be followed by all health care workers(HCW) 
have been prescribed, which are called Universal Barrier Precautions(UBP), so named 
because these have to be followed by HCW towards all patients irrespective of the HIV 
status. This is so because we do not actually know whether a particular patient is HIV 
infected or not and hence we have to treat each patient as though he is HIV positive, to 
prevent transmission among health care workers. 
Risk of Transmission 
 Exposure to HIV is a matter of concern for HCW. In a health care set-up, 
possible routes of transmission are: 
1. from patients to health care persons 
• Percutaneous exposure 0.3% 
• Mucocutaneous exposure 0.05% 
2. from patients to patients. 
3. from HCW to patients. 
4. from patients to community via environment. 
Rationale for practising Universal Barrier Precautions(UBP) in health care facility 
 The reasons for adopting UBP in a health care facility: 
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1. So far no preventive vaccines or effective cure for HIV disease are 
available. 
2. UBP protect the health care providers and the patients against all blood 
borne pathogens like Hepaitits B etc. 
3. Patients may be asymptomatic at the time of presentation and yet they are 
capable of transmitting the infection. 
4. UBP preclude the need for screening patients before any invasive 
procedures. 
5. Screening all patients is not a solution, as in the window period the 
routinely done tests for HIV are negative . 
 
Important aspects of UBP: 
1. Conscientious personnel practices with respect to hygiene,  handwashing and 
use of protective apparel. 
2. Careful attention to patient care practices that minimize transmission of 
infectious agents. 
3. Sanitation measures designed to reduce the number of infectious agents 
present in the health care facility. 
THE ABOVE PRECAUTIONS ARE INTENDED TO ISOLATE THE VIRUS IN 
BLOOD AND BODY FLUIDS AND NOT THE PATIENT. 
The components of UBP are: 
1. Wearing two pairs of gloves whenever contact with blood or body fluids is 
expected. 
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2. Using visors, mask, gown and boots to protect from splashes with infective 
material. If a splash occurs into the eyes, allow a second person to keep the 
eyes open and then flush copiously with water. 
3. Covering cuts and abrasions with waterproof dressings. 
4. Washing hands before and after patient contact and after removal of gloves. 
A 30 second wash with soap and running water removes transient flora. 
5. Preventing needle stick injuries and accidental cuts by  
• doing the procedures slowly and steadily. 
• Always carrying the gloves in your pockets. 
• Avoiding recapping of needles. 
• Avoiding bending/mutilation of used needles with hand,(Needle 
destroyers can be used) 
• Avoiding guiding needles with fingers. 
• Use needle holder while suturing with needle. 
• Avoid passing sharps hand to hand. 
• Disposing needles and other sharps into assigned containers. 
6. If any cuts happen to occur during invasive procedures, 
• remove the gloves. 
• Allow the blood to flow freely without squeezing. 
• Wash with running water. 
• Apply antiseptics.  
• Cover the wound with water proof dressings. 
• Practice PEP(Post Exposure Prophylaxis). 
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7. Soiled surfaces should be covered with paper/rags and flooded with sodium 
hypochlorite. Dispose this into waste bags for incineration. Then wipe the 
surface with disinfectants. 
8. Infectious reusable and heat stable articles, such as glass syringes, surgical 
instruments etc. should be cleaned thoroughly and sterilized in an autoclave 
at the appropriate temperature, pressure and holding period. 
Dry heat  :           hot air oven 160 to 170° C for one hour. 
Autoclaving:        121°C, 15 to 20 pounds pressure, 15  to 20 minutes.   
Boiling  :              100°C, 20 minutes. 
Indicator strips can be used to check hot air oven and autoclaving procedure. 
9. Infectious heat sensitive reusable articles such as scopes, drainage tubes, etc., 
should be treated with high level disinfectants such as Glutaraldehyde and 
Ethylene Oxide. 
10. Appropriate and timely disposal of infectious waste will protect 
medical/paramedical and the community at large from accidental exposure 
to micro-organisms including HIV. Wastes can be put into color-coded bags 
based on the recommendations of the national hospital waste management 
policy. 
• Disposable syringes, needles and other sharps should be treated by 
disinfectants and mutilated and collected in puncture proof non-
collapsible containers for subsequent chemical treatment and 
destruction/shredding. Such treated items can be disposed as general 
waste. 
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• Plastic disposables such as Intravenous sets, gloves, catheters etc., 
must be disinfected, followed by shredding to prevent reuse and can 
be considered for disposal at municipal landfill. 
• Biological wastes such as tissues can be put into waterproof bags and 
sent for incineration/deep burial. 
11. Disinfectants which are effective against HIV. 
Fresh sodium hypochlorite                       1%(Liquid bleach) 
Glutaraldehyde                                         2%(cidex) 
Lysol                                                         3% 
Ethyl alcohol                                              70% 
Fresh Hydrogen peroxide                          3% 
• Disinfectants not to be further diluted. 
• Disinfectants to be used fresh after each cycle. 
• Minimum contact time of 30 minutes recommended 
12. Mandatory screening of all blood and blood products by approved tests 
before transfusion. 
Theatre Sterilisation 
• Soap and water wash followed by Lysol cleaning after the day’s 
surgeries. 
• Fumigation with 40% Formaldehyde (500 ml. for 1000 cubic feet space) 
for 24 hours every week. 
• Theatre sterility checks every 6 months for commissioned theatres. 
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• For new theatres and after civil works, 3 negative sterility reports to be 
obtained. 
Guidelines in ENT Department  
Endoscopes: 
All scopes to be disinfected with 2% cidex for 30 minutes, followed by 3 to 4 
rinses with sterile water after each use. 
Instruments: 
 All outpatient instruments and reusable instruments should be autoclaved before 
each use. 
Others: 
 Use disposable mask and gloves for each patient. 
 All health care personnel to be vaccinated against blood borne pathogens, if 
available(Hepatitis B vaccine). 
 Thus by ensuring proper disposal of infectious waste at its site of generation 
adequate hand washing, preventing needle pricks, proper sterilization and disinfection, 
and by wearing appropriate apparel, we can break the chain of transmission of HIV and 
other blood borne pathogens at our health care facility. All these precautionary 
measures were strictly followed wherever and whenever necessary during this study to 
prevent the transmission of HIV. 
 All the patients were given appropriate treatment, including Anti-Retroviral 
Therapy and the followed up.   
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                                                   RESULTS 
 
                      Out of the 50 patients studied 33 patients were males and 17 were females.     
 
TABLE I      SEX DISTRIBUTION OF THE PATIENTS  
  
  
   
No.of patients(n) 
 
Percentage 
 
 
MALES 
            
           33  
     
        66% 
 
 
FEMALES 
           
           17 
         
         34% 
 
  
                       The age distribution of the patients were as follows: 
 
 
TABLE II      AGE DISTRIBUTION 
 
 
 
AGE GROUP 
 
NO. OF 
PATIENTS  
 
PERCENTAGE 
 
 
20-29 YRS 
             
              4 
         
            8% 
 
 
30-39 YRS 
            
            33 
        
         66% 
 
 
40-50 YRS 
              
            13 
       
        26% 
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The  Socio-economic status of the patients were as follows: 
 
 
                                TABLE III SOCIO-ECONOMIC STATUS  
 
 
 
 
 
NO. OF PATIENTS 
 
PERCENTAGE 
 
 
LOW 
               
                30 
          
            60% 
 
 
MIDDLE 
               
                15 
           
            30% 
 
 
HIGH 
                 
                 5 
            
            10% 
 
 
 
 TABLE IV: FREQUENCY OF EAR, NOSE,THROAT AND NECK  
 
                         MANIFESTATIONS IN HIV INFECTION 
 
    
 
EAR 
 
 
      24% 
 
NOSE 
 
 
      14% 
 
THROAT 
 
      
      74% 
 
NECK 
 
 
      30% 
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 The frequency of various ENT manifestations seen were as follows: 
 
 
TABLE V  FREQUENCY OF ENT MANIFESTATIONS 
 
 
 
 
ENT MANIFESTATIONS 
 
 
 
NO. OF PATIENTS  
 
 
PERCENTAGE 
 
ORAL CANDIDIASIS 
 
 
20 
 
40% 
 
TUBERCULOUS LARYNGITIS 
 
 
4 
 
8% 
 
CERVICAL LYMPHADENOPATHY 
 
 
15 
 
30% 
 
CHRONIC SINUSITIS 
 
 
5 
 
10% 
 
NASALPOLYP 
 
 
2 
 
4% 
 
HERPES SIMPLEX 
 
 
10 
 
20% 
 
ORAL HAIRY LEUKOPLAKIA 
 
 
2 
 
4% 
 
SENSORINEURAL HEARING LOSS 
 
 
10 
 
20% 
 
KAPOSI’S SARCOMA 
 
 
1 
 
2% 
 
CHRONIC OTITIS MEDIA 
 
 
2 
 
4% 
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              According to table I, out of the 50 HIV positive patients included in our study 
33 of them were males (66%) and 17 of them were females (34%). 
             According to table II, out of the HIV positive patients, 66% (n=33) were 
between the age group of 30-39 years. 26% (n=13) were between the age group of 40-
50 years, while only 8% (n=4) were between 20-29 years. 
               The analysis of socio-economic status of the patients is given in table III. 30 of 
them (60%) belong to low socioeconomic group. 15 of them (30%) were of middle 
socioeconomic group. Only 5 (10%) of them belong to high socioeconomic group. 
 According to table IV, Ear manifestations were of 24%, Nose, 14%, Throat, 
74% and Neck 30%. 
 The frequency of various ENT manifestations is shown in table V.  Here 20 of 
the patients had oral candidiasis ie. 40%. 15 (30%) of them had cervical 
lymphadenopathy. 10(20%) of them had herpes simplex and another 10(20%) had 
sensorineural hearing loss. 4(8%) patients had tuberculous laryngitis. 5(10%) patients 
had chronic sinusitis. 2(4%) patients had nasal polyps, 2(4%) had oral hairy leukoplakia 
and 2(4%) others had chronic otitis media. Only 1 patient had kaposi’s sarcoma.  
 20(40%) patients had more than one ENT manifestations. 
 1.oral candidiasis + sensorineural hearing loss                          =    5 
         
 2. cervical lymphadenopathy + nasal polyps                             =    1 
   
 3.cervical lymphadenopathy + sensorineural hearing loss        =    5 
 
 4. oral candidiasis + chronic otitis media                                   =    1 
 
 5. oral candidiasis + nasal polyp                                                =    1 
 
 6. oral herpes simplex + chronic sinusitis                                  =     2 
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 7.cervical lymphadenopathy + oral hairy leukoplakia               =    1 
 
 8.cervical lymphadenopathy + chronic otitis media                   =   1 
 
 9.oral candidiasis + sinusitis                                                       =    2 
 
 10.cervical lymphadenopathy + oral candidiasis                        =    1 
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                                 DISCUSSION 
 
 This study evaluated ENT manifestations in 50 HIV infected patients and the 
frequency of ENT manifestations is discussed as below. 
  Here, as per table I, 33 patients were males and 17 patients were females. That is 
66% of patients were males and 34% of them were females. 
 Generally, males outnumber females in our society, because males are outgoing 
and they are the economically productive members of our society. Females are 
generally neglected and they are ignorant and only if they are given special attention by 
males or elders in the family, they seek medical attention. Since males go out at any 
time and they have better social contact, they are better informed and they seek medical 
attention earlier and easily than females. So this should be the reason why males 
outnumber females in this study.  
 Increased incidence in females is seen in commercial sex workers (CSW). In 
males increased incidence is seen in lorry drivers owing to increased exposure to 
multiple sex partners, in homosexuals and Intravenous drug abusers (IVDA). 
 As per table II 33(66%) patients were of the age group 30 -39 years, 13(26%) 
patients were of the age group 40-50 and 4 (8%) patients were of the age group 20-29 
years. Hence the commonest age group, affected in this study was 30-39 years. This is 
the age group that is most economically productive in the society. They have more 
exposure. Also even if they were exposed in younger age the manifestations become 
apparent after some years only. This is the reason why this age group is the most 
common affected group. 
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 As per table III the people in low socioeconomic status group were the most 
commonly affected. 60% (n=30) of the patients belong to low socioeconomic group. 
30% (n=15) were of middle socioeconomic status and only 10% (n=5) belong to high 
socioeconomic status. This is so because only low socioeconomic status people are 
more ignorant, illiterate and do not know or follow safe sexual practices. Also STDs are 
more common in low socioeconomic group due to poor hygiene, crowding and 
ignorance regarding early consultation and also several myths are commoner in low 
socioeconomic group. Also native and traditional treatments are followed among low 
socioeconomic group people commonly. STDs naturally increase the risk of 
transmission of HIV. 
 According to table IV, throat manifestations, which comprise of Oral candidiasis, 
Oral herpes simplex, tuberculous laryngitis, kaposi’s sarcoma and Oral hairy 
leukoplakia were the commonest (74%). Nose manifestations which comprise of 
chronic sinusitis and nasal polyps were of 14%. Ear manifestations which comprise of 
chronic otitis media and sensorineural hearing loss were of 24%. Neck manifestation 
which comprises of only cervical lympadenopathy was of 30%. 
 According to table V, the most common ENT manifestation among 50 HIV 
infected patients happened to be Oral candidiasis which occurred in 20(40%) patients, 
30%(n=15) had cervical lymphadenopathy out of which only 2(4%) patients had 
tuberculous lymphadenitis and all others had chronic nonspecific inflammatory reaction 
or chronic reactive hyperplasia of lymph nodes. 20%(10) had oral herpes simplex 
lesions and 20%(n=10) had sensorineural hearing loss. 10%(n=5) had chronic 
sinusitis.8%(n=4) had tuberculous laryngitis. 4%(n=2) had chronic otitis media, another 
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4%(n=2) had nasal polyps, which turned out to be fungal sinusitis. Oral hairy 
leukoplakia occurred in 2 (4%) patients. Only 2% (n=1) had kaposi’s sarcoma. 
ORAL CANDIDIASIS 
 Candidiasis is the most common fungal infection in patients with AIDS.8 Out 
of the 50 patients studied 40%(n=20) had oral candidiasis. We have got 3 types of oral 
candidiasis occurring in HIV infected patients. 
1. Pseudomembranous candidiasis  
2. Erythematous candidiasis and 
3.
 Hypertrophic candidiasis.66 
Here the most common type observed was pseudomembranous candidiasis 
which occurred in 80%(n=16), erythematous candidiasis occurred in 15%(n=3) 
and only 5%(n=1) had hypertrophic candidiasis. 
 According to Deb T Singh NB et al 16 oral candidiasis occurred in 
22.5% of HIV infected patients they studied. As per Laskaris G Hadjivassilon 
M et al,33 oral candidiasis occurred in 61% of HIV infected patients they studied. 
 60% of the HIV infected patients had oral candidiasis in a study by 
Herdman Re, Forsters et al.26 35% of the HIV infected patients had oral 
candidiasis in a study conducted by Lim AA Leoys et al39 
 According to Reoderer A et al52 only 36.3% had oral candidiasis in a 
study conducted by them in HIV infected patients. 
 According to Ondzotto G Ibara JR et al46 14.6% of HIV infected 
patients had oral candidiasis. Oral candidiasis is one of the earliest  and most 
frequent of the opportunistic infections in patients with HIV/AIDS. 
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 Candida species which frequently cause human infections, grow as 
yeasts, elongated chains of yeast without hyphae(pseudohyphae) or septate 
hyphae. Mucocutaneous candidal infections can produce white plaques called 
thrush15 
 Candidiasis is otherwise called candidosis or moniliasis. It is an infection 
of the skin, mucosa and rarely of the internal organs, caused by a yeast like 
fungus Candida albicans, and occasionally by other candida species. 
 Candida albicans is an ovoid or spherical budding cell, which produces 
pseudomycelia both in culture and in tissues. Candida species are normal 
inhabitants of the skin and mucosa. Candidiasis is an opportunistic endogenous 
infection, the commonest predisposing factor being Diabetes. But it is one of the 
commonest opportunistic infection in HIV/AIDS. Oral candidiasis is otherwise 
called oral thrush found commonly in bottle fed infants and the aged and 
debilitated and in immunosuppressive conditions like HIV/AIDS. Creamy white 
patches appear on the tongue or buccal mucosa, that leave a red oozing surface 
on removal.4 
Diagnosis 
 The diagnosis is mainly based on clinical features and history. However 
diagnosis can be established by microscopy and culture. Wet films or gram stained 
smears from lesions or exudates show budding  Gram positive cells. As candida can be 
seen on normal skin or mucosa as well, only its abundant presence is of significance. 
Demonstration of mycelial forms indicates colonization and tissue invasion and is, 
therefore, of greater significance. Cultures can be obtained readily on sabouraud’s and 
on ordinary bacteriological culture media. Colonies are creamy white, smooth and with 
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a yeasty odour.  Candida albicans can be identified from other candida species 
(C.stellatoidae,C.tropicalis, C.pseudotropicalis, etc.,) by growth characteristics and 
sugar assimilation and fermentation tests. C.albicans alone forms chlamydospores on 
corn meal agar cultures at 20°C. A rapid method of identifying C.albicans is based on 
its ability to form germ tubes within 2 hours when incubated in human serum at 37°C. It 
is called Reynolds-Braude phenomenon.4 
CERVICAL LYMPHADENOPATHY 
 In this study, 30% (n=15) of the patients had cervical lymphadenopathy out of 
which 4%(n=2) of the patients had tuberculous lymphadenitis. Most of the patients had 
non specific chronic inflammatory reaction and some had reactive hyperplasia of lymph 
nodes.  
 According to Larkasis G Hadjivassilou M et al,33 49% of HIV infected 
patients had cervical lymphadenopathy.As per Herdman Re Forsters et al,26 27% of 
HIV patients had cervical lymphadenopathy. According to Marcusen DL et al, 8% of  
HIV patients had cervical lymphadenopathy. 
One of the earliest signs of HIV infection is persistent generalized 
lymphadenopathy, also known as HIV lymphadenopathy. This entity is defined as 
unexplained generalized lymphadenopathy, involving two or more extra inguinal sites 
and lasting more than three months. The axilla is the most common site of 
lymphadenopathy, but head and neck sites are also very common. Patients often have 
no symptom other than neck swelling. Tissue sampling should be performed when 
malignancy is suspected. Indications for biopsy include recent weight loss, and lymph 
nodes that rapidly increase in size, and are firm or non mobile.  
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A number of opportunistic and nonopportunistic infections involving the neck 
present as cervical lymphadenopathy or an enlarging neck mass The incidence of 
Mycobacterium tuberculosis infection has increased in HIV-positive patients, and 30 to 
50 percent of these infections have extrapulmonary involvement. Of extrapulmonary 
sites, the cervical lymph nodes and the bone marrow are most commonly involved. 
Lymph nodes are firm and non tender.  
Purified protein derivative (PPD) tests, along with skin testing, is indicated in 
cases in which tuberculosis is suspected. In HIV-positive patients, any skin reaction 5 
mm or more in diameter is considered a positive result. If no response is noted on the 
skin test, other modes of diagnosis, such as fine-needle aspiration or tissue biopsy, are 
indicated. Definitive diagnosis is made by culturing the organism. It is important to rule 
out pulmonary and systemic involvement after diagnosing cervical tuberculous 
lymphadenitis.  
Mycobacterium avium complex is the most common type of mycobacterial 
infection among HIV-positive patients. The disseminated form of the disease occurs in 
approximately 10 to 20 percent of patients with end-stage AIDS. This organism can be 
present in cervical lymph nodes, as well as other sites of dissemination, but it 
commonly appears in blood. M. avium complex is an acid-fast bacillus that can be 
located within foamy macrophages using Fite's method. Blood culture remains the 
unequivocal method of diagnosing disseminated M. avium complex infection. 
As with tuberculosis, systemic involvement should be ruled out when M. avium 
complex has been identified in cervical lymph nodes. 
Pulmonary histoplasmosis and coccidioidomycosis are increasing in frequency 
along with the increase in incidence of HIV-positive patients in their endemic areas. 
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When cervical fungal lymphadenitis is diagnosed, disseminated fungal infection should 
also be considered.   
Parotid gland involvement is common in patients with HIV and can result from 
a wide range of pathologic conditions. Lymphoepithelial cyst of the parotid is unique to 
HIV-positive patients. Often these patients have bilateral progressive swelling and 
tenderness at the angle of the mandible or upper neck. Tissue biopsy can be used as an 
adjunct to CT scan and fine-needle aspiration for diagnosis. 
The pathogenesis of these true cysts remains unclear. They have a very benign 
course but at times grow fairly large. Repeated needle aspirations may be required to 
decompress the cysts. 
A neck mass in an HIV-infected person can also be the presenting form of 
fungal infection, including cryptococcosis, histoplasmosis and coccidioidomycosis, for 
which the incidence is determined by geographic distribution of the organism. 
Cryptococcal meningitis is a more common presenting manifestation in HIV-infected 
patients. 
Cervical lymph node hyperplasia is ubiquitous in HIV positive patients.65 
Biopsy specimens from enlarged lymph nodes in the early stages of HIV infection 
reveal a marked follicular hyperplasia. The enlarged follicles have irregular, sometimes 
serrated borders, and they are present not only in the cortex, but also in the medulla and 
may even extend outside the capsule. The mantle zones that surround the follicles are 
markedly attenuated, and hence the germinal centres seem to merge with the 
interfollicular area. These changes, affecting primarily the B-cell areas of the node, are 
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the morphologic reflections of the polyclonal B-cell activation and 
hypergammaglobulinemia seen in patients with AIDS.  
In addition to B-cell expansion within germinal centers, activated monocytoid B 
cells are present within and around the sinusoids and trabecular blood vessels.  Under 
the electron microscope and by in situ hybridization, HIV particles can be detected 
within the germinal centers. Here they seem to be concentrated on the villous processes 
of follicular dendritic cells, presumably trapped in the form of immune complexes. 
During the early phase of HIV infection, viral DNA can be found within the nuclei of 
CD4+ T cells located predominantly in the follicular mantle zone. With disease 
progression, the frenzy of B-cell proliferation subsides and gives way to a pattern of 
severe follicular involution. The follicles are depleted of cells, and the organized 
network of follicular dendritic cells is disrupted. During this advanced stage, viral 
burden in the nodes is reduced, in part because of the disruption of the follicular 
dendritic cells. 
 These burnt-out lymph nodes are atrophic and small and harbor numerous 
opportunistic pathogens. Because of profound immunosuppression, the inflammatory 
response to infections both in the lymph nodes and at extranodal sites may be sparse or 
atypical. For example mycobacteria may not evoke granuloma formation because CD4+ 
cells are deficient. In the empty-looking lymph nodes and in other organs, the presence 
of infectious agents may not be readily apparent without the application of special stains. 
Molecular analyses have revealed an alarming degree of polymorphism in viral isolates 
from different patients.15 
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Tuberculous lymphadenitis 
 The most common extrapulmonary site of tuberculous disease is the lymph 
nodes. Cervical and mediastinal glands are affected most frequently, followed by 
axillary and inguinal, in 55 of patients, more than one region is involved. 
Supraclavicular lymphadenopathy is usually a result of spread from mediastinal disease. 
The nodes are usually painless and initially mobile but become matted together with 
time. When caseation and liquefaction occur, the swelling becomes fluctuant and may 
discharge through the skin with the formation of a collar-stud abscess and sinus 
formation. Approximately half of patients fail to show any constitutional features such 
as fevers and night sweats.66 
ORAL HERPES SIMPLEX 
 In this study 20% (n=10) of the patients had oral herpes simplex lesions. 
According to Reiderer A et al,52 10% of HIV positive patients had oral herpes simplex. 
According to Kamim HN et al, 12% of HIV positive patients had oral herpes simplex 
lesions. 
 Herpes simplex infections occur at a higher frequency in the HIV-positive 
population than in the general population. Of the two subtypes, HSV-1 and HSV-2, the 
former is far more commonly the causative agent of lesions in the oral cavity. Herpes 
labialis is the most common presentation of this infection. In HIV-infected patients, 
however, these lesions are larger and more numerous, recur more frequently and last 
longer than such lesions in HIV-negative patients. The lesions appear as ulcerations 
with raised borders  and are painful and tender to touch. They occur on heavily 
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keratinized mucosal surfaces. Tests of the borders of the ulcer using Tzanck preparation, 
or viral cultures, help in confirming the diagnosis. 
 Herpes simplex is one of the most common viral infections in humans, about 60-
90 percent of adults showing detectable antibody.  Primary infection is usually acquired 
in early childhood, between two and five years of age. Humans are the only natural 
hosts and the sources of infection are saliva, skin lesions or respiratory secretions. 
Asymptomatic carriers form the more important source of infection, especially in 
genital infection with type 2 strains. Transmission occurs by close contact and may be 
venereal in genital herpes.  
          The virus enters through defects in the skin or mucous membranes and multiplies 
locally, with cell-to-cell spread. The virus enters cutaneous nerve fibres and is 
transported intraaxonally to the ganglia where it replicates. Centrifugal migration of the 
virus can take place from the ganglia to the skin and mucosa to cause cutaneous and 
mucosal lesions. The virus remains latent in the ganglia, particularly of the trigeminal 
(HSV type 1) and sacral (HSV type 2) nerves, to be reactivated periodically in some 
individuals causing recurrent oral and genital lesions. Antibodies may not prevent 
recurrences, but can reduce the severity of clinical disease. Cell mediated immunity is 
more important in resistance to and recovery from herpes simplex infections. Herpes 
virus diseases are more frequent and severe in the HIV infected and other immuno 
deficient subjects. 
The typical herpes lesions are thin walled, umbilicated vesicles, the roof of 
which breaks down, leaving tiny superficial ulcers. They heal without scarring. In 
general, primary infections, though self-limited, are more severe and widespread and 
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associated with systemic manifestations. Recurrent infections are more localized. For 
cutaneous infections the most common site is the face-on the cheeks,chin, around the  
mouth or on the forehead. The buccal mucosa is the site most commonly affected. 
Gingivostomatitis and pharyngitis are the most frequent conditions in primary infection 
and recurrent herpes labilais in recurrent infection. The vesicles may ulcerate and 
become secondarily infected. 
Diagnosis    
 The diagnosis of herpes virus infection is usually made by clinical features and 
may be made by microscopy, antigen or DNA detection, virus isolation or serology. In 
this study Tzanck smear is done for diagnosis. The Tzanck smear is a rapid, fairly 
sensitive and inexpensive diagnostic method. Smears are prepared from the lesions, 
preferably from the base of vesicles/ulcers and stained with 1% aqueous solution of 
toluidine blue ‘o’ for 15 seconds. Multinucleated giant cells with faceted nuclei and 
homogeneously stained ground glass chromatin (Tzanck cells) constitute a positive 
smear. 
  Intranuclear type A inclusion bodies may be seen in Giemsa stained smears. 
The virus particle may also be demonstrated under the electron microscope.4 
 SENSORINEURAL HEARING LOSS 
 In this study sensorineural hearing loss occurred in 20% (n=10) of the 50 HIV 
positive patients studied, had sensorineural hearing loss. All of them had mild to 
moderate type of sensorineural hearing loss. 
 According to Somofun A Nwawolo CC et al,59 30.6% of patients with HIV 
infection had sensorineural hearing loss. According to Sant Anna GD et al,56 25% of 
HIV positive patients had sensorineural hearing loss. 
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In general, otologic manifestations are less common than other head and neck 
manifestations. Some of the more common complications include otitis externa, serous 
otitis media, Kaposi's sarcoma, eustachian tube obstruction secondary to 
nasopharyngeal mass, acoustic brainstem response abnormalities and sensorineural 
hearing loss secondary to central nervous system complications. 
As many as 20 to 50 percent of HIV-positive patients have sensorineural hearing 
loss.Since HIV is a known neurotropic virus, sensorineural hearing loss may be 
explained by direct involvement of the eighth cranial nerve, although no pathologically 
documented case has been reported. On the other hand, central nervous system 
complications of AIDS, such as cryptococcal meningitis or neurosyphilis, can also 
cause sensorineural hearing loss. Evaluation includes a complete audiogram, speech and 
impedance audiometry, and acoustic reflex testing. Retrocochlear pathology can be 
assessed by acoustic brainstem response testing. Cerebrospinal fluid should be sent for 
detection of Treponema pallidum and cryptococcal antigen. Hearing aids can benefit 
patients with significant hearing loss. 
Sensorineural hearing loss is among the numerous neurologic manifestations of 
AIDS. The hearing loss may be a result of an infectious complication of AIDS, 
particularly cryptococcal meningitis or syphilis, or as a primary neurologic 
manifestation of the disease. Human immunodeficiency virus(HIV) should be a 
consideration in patients with otherwise unexplained sensorineural hearing loss when 
risk factors are present.3 In this study only Pure Tone Audiogram was done to assess the 
degree and type of hearing loss. 
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CHRONIC SINUSITIS 
 In this study, 8% (n=4) of the patients had chronic sinusitis which was 
diagnosed with the help of diagnostic nasal endoscopy and computed tomography(CT) 
of paranasal sinuses. 
 According to Deb T singh NB et al16, 27.5% of HIV positive patients had 
chronic sinusitis. According to Ondzotto G Ibara JR et al,4614.2% of HIV positive 
patients had chronic sinusitis. 
The prevalence of rhinosinusitis ranges from 20 to 70 percent in patients with 
AIDS. Sinusitis is a spectrum of inflammatory diseases involving the nose and 
paranasal sinuses. This spectrum includes acute and chronic sinusitis, with or without 
mucopurulent postnasal drainage. The organisms that cause acute sinusitis in both 
immunocompromised and immunocompetent populations include S. pneumoniae and H. 
influenzae. Staphylococcus aureus and P. aeruginosa are more commonly associated 
with chronic sinusitis.  
Just as in hosts without HIV infection, HIV-positive patients with sinusitis have 
signs and symptoms of fever, general and localized headaches, and mucopurulent 
drainage from sinus ostia. Computed tomographic (CT) scan of the sinuses determines 
the extent of disease. 
Patients with AIDS appear to have an increased incidence of sinusitis, although 
most reports are anecdotal. In addition to the usual organisms of sinusitis, AIDS 
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patients have an increased likelihood of culturing pseudomonas and unusual organisms 
such as Legionella pneumophila and Pneumocystis carinii. Cases of invasive fungal 
sinusitis in patients with AIDS are not unusual, but the overall incidence of fungal 
sinusitis is unknown. AIDS patients with low CD4 counts may show evidence of hyper-
IgE conditions, including allergic rhinitis with severe congestion and thick nasal 
secretions.40 
In this study, pus from middle meatus and nasal cavity was taken and a study of 
culture made. The organisms found out were Streptococcus pneumoniae, Hemophilus 
influenza and Proteus.  
TUBERCULOUS LARYNGITIS 
 Here. 4%(n=2) of patients had tuberculous laryngitis which was diagnosed 
based on clinical features, history and histopathological examination of suspected 
lesions of larynx. 
 According to Lee KC et al, 12% of HIV positive patients had tuberculous 
laryngitis.37As per Cantwell MF et al,8  30% of HIV patients had pulmonary 
tuberculosis and only 6% had tuberculous laryngitis. 
It is estimated that tuberculosis is 100 to 500 times more common in HIV-
positive patients. This is not surprising because the main defense against mycobacteria 
is cell mediated immunity. Singh et al, have reviewed laryngeal tuberculosis in HIV-
positive patients. The most common symptoms were hoarseness, odynophagia and 
shortness of breath. The majority of the patients had white exophytic lesions which may 
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involve any area of the larynx and looked like carcinoma or chronic laryngitis. Systemic 
symptoms such as fever, night sweats, and weight loss are very common in AIDS 
patients and coupled with other illnesses masked the possibility of laryngeal disease. 
This may delay the diagnosis of laryngeal tuberculosis.  
The diagnosis is made by tissue examination and culture. Polymerase chain 
reaction identifying tuberculous DNA shows potential in making this diagnosis more 
rapidly. Cultures should be obtained to determine drug susceptibility because of the 
high incidence of multi-drug resistant tuberculosis. 
90% of cases of laryngeal tuberculosis are associated with active pulmonary 
tuberculosis making this a contagious illness. Therefore patient isolation is needed as 
long as the patient has potentially infectious sputum. Adequate room 
ventilation/filtration and masks for all health care providers are necessary. The 
individual must have a chest x-ray and a PPD test (although many AIDS patients are 
allergic) to check for active tuberculosis. 
 The most common presenting symptom of laryngeal tuberculosis is hoarseness, 
with a high percentage of patients also reporting dysphagia, odynophagia, cough, and 
weight loss. 20-40% of patients show no evidence of pulmonary involvement, but 
purified protein derivative is usually positive. Almost any area of the larynx can be 
involved as well as supraglottic structures such as the aryepiglottic folds and epiglottis. 
Lesions range from areas of nonspecific inflammation to a nodular, exophytic lesion or 
mucosal ulcerations. Histopathological examination of biopsied tissue reveals tubercles 
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consisting of a homogenous caseous center (staining red with eosin), a periphery of pale 
epithelial cells containing one or more giant cells, and an outer zone of lymphocytes. 
 
CHRONIC OTITIS MEDIA 
 4%(n=2) of 50 HIV patients had chronic otitis media which was diagnosed 
based on history, clinical examination. Pus was taken and culture of the pus done. 
According to Shapiro et al, 15% of HIV patients had chronic otitis media. According to 
Rarey et al,2% of HIV patients had chronic otitis media. 
Serous otitis media, (i.e., middle ear effusion without inflammation) is more 
prevalent in the adult AIDS population than in the general population. It can result from 
a malfunctioning eustachian tube secondary to recurrent viral infections, adenoidal 
hypertrophy, nasopharyngeal tumors or allergies. 
Unilateral or recurrent serous otitis media warrants evaluation of the 
nasopharynx to rule out large benign or malignant nasopharyngeal tumors. These 
lesions present as nasal obstruction, hearing loss, otitis media and recurrent serous otitis 
media. The presence of large lymphoid proliferation of the adenoids  in a patient should 
prompt the physician to obtain a good history of risk factors and to perform serologic 
testing for HIV.  
Acute otitis media is common in patients with AIDS. Symptoms, causative 
agents and treatment of acute otitis media are similar in patients with AIDS and in the 
general population. The predominant agents are Streptococcus pneumoniae, 
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Haemophilus influenzae and Moraxella catarrhalis. Otitis media and mastoiditis caused 
by Pneumocystis carinii are uncommon opportunistic otologic infections unique to 
patients with AIDS. An aural polyp is frequently found in the external auditory canal or 
middle ear that, on biopsy, reveals a typical P. carinii cyst if stained with Grocott-
Gomori methenamine silver nitrate. P. carinii gains access to the middle ear in three 
ways: (1) it can extend retrogradely through the eustachian tube from a colonized 
nasopharynx, (2) it can spread medially from the external auditory canal or (3) it can 
seed the temporal bone hematogenously. 
NASAL POLYPS 
 In this study 4% (n=2) of the patients had nasal polyps which turned out to be 
fungal sinusitis on doing fungal staining. According to Lee KC et al,36 8% of HIV 
patients had fungal sinusitis with nasal polyps. According to Shapiro AL et al, 5% of 
HIV patients had nasal polyps. 
 Causative organisms include atypical opportunistic organisms as well as agents 
responsible for sinusitis in hosts without AIDS. Opportunistic fungal sinusitis is caused 
by organisms such as Alternaria alternata, Aspergillus, Pseudallescheria boydii, 
Cryptococcus and Candida albicans. 
ORAL HAIRY LEUKOPLAKIA 
4% (n=2) of the patients had oral hairy leukoplakia which was diagnosed based 
on history, characteristic clinical feature and histopathological examination. 
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 According to Larkaris G Hadjivassilou M et al33 24% of HIV positive 
patients had oral hairy leukoplakia. According to Lim AA Leoys et al39 5% of HIV 
positive patients had oral hairy leukoplakia. According to Reoderer A et al,52 5% of 
HIV patients had oral hairy leukoplakia. 
Hairy leukoplakia is a newly recognized, coarsely textured lesion of the oral 
cavity, unique to HIV-positive persons. It is a white lesion that forms most often on the 
lateral borders of the tongue. The lesion is raised, cannot be scraped off and has a hairy 
appearance. It resembles the hyperplastic form of candidiasis that is refractory to 
antifungal therapy. The lesion often indicates progression to full-spectrum AIDS. 
Epstein-Barr virus has been suggested as the causative agent. 
KAPOSI’S SARCOMA 
 In this study, about 2% (n=1) of patients had kaposi’s sarcoma diagnosed by 
history, typical clinical appearance, site and histopathological examination. This patient 
had smooth, pink, fleshy irregular mass over the left side of the hard palate which has 
been shown in the photograph attached. On taking biopsy from the lesion, the 
histopathological feature confirmed kaposi’s sarcoma. The patient is a known case of 
AIDS, under Anti-Retroviral Treatment (ART). His CD4+ T cell count was 50 
cells/cu.mm.   
 According to Larkaris G Hadjivassilou M et al,33 12% of HIV patients had 
kaposi’ s sarcoma. According to Herdman Re, Forster et al,26 26% of HIV patients 
had kaposi’s sarcoma. 
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Kaposi's sarcoma is by far the most common oral neoplasm in AIDS patients. It 
is more common among homosexual and bisexual males with AIDS than in persons 
who contracted the HIV virus from any other source. Kaposi's sarcoma in patients under 
60 years of age almost always indicates AIDS and fulfills the Centers for Disease 
Control and Prevention's requirement for the definition of AIDS. 
The palate serves as the site for 95 percent of these oral lesions, while any other 
mucosal surface of the mouth can also be a site. In the early stages, the lesions are 
macular, dark or erythematous, maturing into more raised and lobulated mucosa. The 
lesions can ulcerate but rarely bleed or become tender. Kaposi's sarcoma is usually slow 
to develop but, in some reported cases, the lesions rapidly disseminate to involve the 
thoracic and abdominal viscera. Symptoms include increasing pain, odynophagia, 
dysphagia and difficulty in mastication. 
 The epidemic form of kaposi’s sarcoma is associated with AIDS. It presents 
with skin lesions anywhere and disseminate to mucous membranes, GI tract, lymph 
nodes and viscera. In the early stages, irregular dilated epidermal vascular spaces, 
extravasated red cells and hemosiderin are characteristic in histological examination. 
This histologic appearance is very similar to that of granulation tissue or stasis 
dermatitis.  
Later in the disease process, more characteristic lesions show spindle cells 
around slit spaces with extravasation of erythrocytes. In contrast, irregular vascular 
spaces lined by nests of uniform cells describes the histologic appearance of glomus 
tumor, while multiple dilated endothelial lined vessels that lack red blood cells 
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describes the histologic appearance of lymphangiomas. Numerous neutrophils, nuclear 
dust and purple granules characterize bacillary angiomatosis, while proliferating blood 
vessels, endothelial cells and fibroblasts suggest granulation tissue.8  Recently it has 
been found out that Human Herpes Virus-8(HHV-8) is associated with the formation of 
kaposi’s sarcoma. 
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                                     CONCLUSION 
1. Out of the 50 HIV positive patients, who had some form of ENT symptoms, 
majority of the patients were of the age group 30-39 years (66%). 
2. Males (66%) outnumbered females (34%) in this study. 
3.  Majority of the patients belong to low socioeconomic group (60%). 
4. This study concluded that the most common ENT manifestation in 
HIV/AIDS is Oral Candidiasis (40%). The next common manifestation is 
Cervical Lymphadenopathy (30%). Other common manifestations are Oral 
Herpes Simplex and Sensorineural Hearing Loss. Less common 
manifestations are, Chronic Sinusitis, Tuberculous Laryngitis, Chronic Otitis 
Media, Oral Hairy Leukoplakia, Nasal polyps and Kaposi’s sarcoma. 
5. Of these lesions Oral candidiasis, Chronic/recurrent mucocutaneous  Herpes 
Simplex, Oral Hairy Leukoplakia and Kaposi’s sarcoma are the AIDS 
defining illnesses. Oral Hairy leukoplakia though rare, is virtually 
pathognomonic of HIV infection. These lesions are specific to HIV/AIDS. 
6. Other nonspecific manifestations like Sensorineural Hearing Loss, Chronic 
Sinusitis etc, are also common in HIV/AIDS. 
7. These manifestations help ENT surgeons, to recognize HIV/AIDS patients 
from the specific ENT lesions occurring in them, for early diagnosis and 
subsequent treatment.   
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                                 PROFORMA 
 
 
Name:                                                                                   Age:                      Sex: 
 
OP No/ART No/IP No:                                                           Occupation:    
 
Marital status:                                   Socioeconomic status:Low/Middle/High 
 
Residence:                                     
 
Sexual activity: Homosexual/Heterosexual/Bisexual/Promiscuous 
 
 H/O IV Drug Abuse: YES/NO          H/O weight loss:YES/NO 
 
 H/O Blood Transfusion: YES/NO 
 
H/O Organ Transplant:Kidney/Bone/Cornea 
 
H/O Chemotherapy formalignancy:YES/NO 
 
H/O HIV in spouse:YES/NO 
 
H/O fever: YES/NO, duration--------------- 
 
H/O diarrhea: YES/NO, duration------------- 
 
H/O Steroid intake/Immunosuppressive therapy: YES/NO 
 
Chief Complaints with duration: 
 
1. oral white patches 
2. oral ulcers 
3. neck swelling 
4. difficulty in swallowing 
5. hoarseness of voice 
6. swelling inside oral cavity 
7. headache/postnasal drip 
8. nasal obstruction/nasal discharge 
9. ear discharge 
10. hard of hearing 
 
Duration of HIV infection:                        Duration of Anti-Retroviral Treatment: 
 
Associated Features:STD/ TB/DM/other malignancies/opportunistic 
 
 infections 
 
Past H/O:STD/TB/DM 
 
Marital H/O: 
 
Family H/O: 
 
                                                            ENT EXAMINATION 
 
Ears: 
 
Tuning Fork Tests: 
 
                                 right ear                                 left ear 
 
Rinnes 
 
Weber 
 
ABC 
 
Pure Tone Audiogram if hearing loss is present: 
 
       Nose: 
 
 
Diagnostic Nasal Endoscopy: if  headache/nasal  
 
obstruction/ postnasal drip/nasal discharge is present: 
 
                                                 right side                                                 left side 
 
 
 
 
 
Throat: 
 
Oral cavity: 
 
Oropharynx: 
 
Indirect Laryngoscopic Examination: 
 
Videolaryngoscopy if needed: 
 
Neck: 
 
                                                      GENERAL EXAMINATION 
 
Mental  status:                               Built/Nourishment: 
 
Weight:                Height:                          Temperature: 
 
Anaemia/Cyanosis/Jaundice/Clubbing/Generalised lymphadenopathy 
 
Pedal edema/Tinea versicolor 
 
PR:                BP:                              RR: 
 
RESPIRATORY SYSTEM: 
 
CARDIOVASCULAR SYSTEM: 
 
ABDOMEN: 
 
CENTRAL NERVOUS SYSTEM: 
 
 
INVESTIGATIONS : 
 
BLOOD: 
 
TC                                        DC:  
 
ESR:                   Hb:                       Sputum AFB: 
 ELISA FOR HIV: 
 
CD4+ T cell count: 
 
Gram stain for candidiasis: 
 
Tzanck smear for herpes simplex: 
 
FNAC: 
 
Pus Nose/Ear C/S: 
 
Histopathological examination: 
 
Pure Tone Audiogram if hard of hearing is present: 
 
DIAGNOSIS: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                ABBREVIATIONS 
 
AFB------------------------------Acid Fast Bacilli 
AIDS-------------------------- --Acquired Immunodeficiency Syndrome 
ART-----------------------------Anti-Retroviral Therapy 
ATT-----------------------------Anti-Tuberculous Treatment 
C/S-------------------------------Culture and Sensitivity 
CD------------------------------Cluster Differentiation 
CP------------------------------Central Perforation 
CSOM-------------------------Chronic Suppurative Otitis Media 
CSW---------------------------Commercial Sex Worker 
CT------------------------------Computerised Tomography 
CXR---------------------------Chest X ray 
dB------------------------------decibel 
DC-----------------------------Differential Count 
DNE---------------------------Diagnostic Nasal Endoscopy 
DSR---------------------------Deviated Nasal Septum to right side 
ELISA------------------------Enzyme Linked Immunosorbent Assay 
ENT---------------------------Ear Nose and Throat 
ESR---------------------------Erythrocyte Sedimentation Rate 
FNAC------------------------Fine Needle Aspiration Cytology 
GI------------------------------Gastrointestinal 
gp -----------------------------Glycoprotein 
H/O---------------------------History of 
Hb-----------------------------Hemoglobin 
HCW--------------------------Health Care Worker 
HIV---------------------------Human Immunodeficiency Virus 
HL----------------------------Hearing Loss 
HSV-1------------------------Herpes Simplex type 1 
HSV-2-------------------------Herpes Simplex type 2 
IDL----------------------------Indirect Laryngoscopy 
IDU---------------------------Injection Drug Users 
IP-----------------------------Inpatient 
IVDA------------------------Intravenous Drug Abuse 
MHC------------------------Major Histocompatibility Complex 
OP---------------------------Outpatient 
PA----------------------------Posteroanterior 
PNS--------------------------Paranasal Sinuses 
PTA-------------------------Pure Tone Audiometry 
RNA------------------------Ribonulceic Acid 
SN--------------------------Sensorineural 
STD------------------------Sexually Transmitted Disease 
TB--------------------------Tuberculosis 
TC--------------------------Total Count 
TFT-------------------------Tuning Fork Tests 
UBP-------------------------Universal Barrier Precautions 
VCTC---------------------------Voluntary Counselling and Testing Centre 
                           STRUCTURE OF HIV  
                           
 
 
               
 MECHANISM OF HIV INFECTION 
                                      
 
 
                                 ORAL CANDIDIASIS 
 
 
 
 
 
 
                                      ORAL HERPES SIMPLEX 
 
 
ORAL HAIRY LEUKOPLAKIA 
 
 
 
  
TUBERCULOUS LARYNGITIS 
 
 
 
         HISTOPATHOLOGY OF KAPOSI’S SARCOMA 
 
 
 
 
 
 
 
 
         HYPHAE SEEN ON GRAM STAIN OF CANDIDIASIS 
  
    
 
   
 
TZANCK CELLS SEEN ON TZANCK SMEAR FOR           
HERPES SIMPLEX         
 
   
                CERVICAL LYMPHADENOPATHY 
  
 
 
 
               KAPOSI’S SARCOMA OVER HARD PALATE    
 
 
  
                                                            CHART I 
 
            
SEX DISTRIBUTION
FEMALES
34%
MALES
66%
FEMALES MALES
 
 
 
 
 
  
 
                                          CHART II 
                
AGE DISTRIBUTION
8%
66%
26%
20-29 YRS
30-39 YRS
40-50 YRS
 
 
                                                          CHART III                      
 
                  
SOCIO ECONOMIC STATUS
10%
30%
60%
HIGH MIDDLE LOW
 
 
                   
                                               CHART V 
 
          
40%
8%
30%
10%
4%
20%
4%
20%
2%
4%
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
PE
RC
EN
TA
G
E
1
FREQUENCY OF ENT MANIFESTATIONS
 ORAL CANDIDIASIS(n= 20) TB LARYNGITIS
CERVICAL LYMPHADENOPATHY SINUSITIS
NASAL POLYP HERPES SIMPLEX
ORAL HAIRY LEUKOPLAKIA SN LOSS
KAPOSI SARCOMA OTITIS MEDIA
 
 
 
 
                                                      CHART IV 
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                                                   MASTER CHART 
 
Sl. 
No. 
Name Age/ 
Sex 
Chief 
Complaint 
Positive clinical 
Features 
Investigations Diagnosis CD4count 
/cu.mm. 
1 Jegan 35/M White 
patches in 
mouth 
White patches on tongue 
on scraping leaves a red 
raw surface 
Gram stain:positive for 
candida 
Oral Candidiasis 400 
2 Jeyanthi 38/F Swelling in 
neck 
Two lymph nodes in 
upper deep cervical 
group,firm mobile 
FNAC:Non specific 
inflammatory reaction 
Non specific 
Cervical 
Lymphadenopathy 
300 
3 Kumar 40/m Oral white 
patches and 
ard of 
hearing 
White patches on buccal 
mucosa on scraping 
leaves red raw surface, SN 
Hearing loss by TFT 
PTA: High frequench 
moderate sensorineural 
hearing loss,Gram 
stain:positive for candida 
Oral Candidiasis 
with Sensorineural 
hearing loss 
150 
4 Sankari 35/F Oral painful 
Ulcers 
Multiple Ulcers in inner 
surface of lips  
Tzanck smear: positive Oral Herpes 
Simplex 
450 
5 Dhandapani 38/M Neck 
swelling, 
nasal 
obstruction 
Cervical 
lymphadenopathy,single 
node in level II, firm 
mobile, nasal polyps 
FNAC:Non specific 
lymphadenitis,DNE:Nasal 
polyps in middle meatus on 
left side, fungal stain positive 
for aspergillus 
 Non specific 
Cervical 
Lymphadenopathy 
with fungal 
sinusitis 
200 
6 Manikandan 36/M Oral white 
patches, 
headache 
White patches on tongue 
on scraping red raw 
surface seen, DSL  
DNE:Pus in middle meatus 
pus C/S:Haemophilus present, 
Gram stain: positive for 
candida,CT PNS:bilateral 
maxillary sinusitis 
Oral Candidiasis 
with Bacterial 
Sinusitis 
100 
7 Dhivya 28/F Oral ulcers Multiple ulcers on lips 
painful 
Tzanck smear:positive Oral Herpes 
simplex 
200 
8 Mohan 33/M Oral white 
patches 
Curdy white patches on 
buccal mucosa on 
scraping leaves red raw 
surface 
Gram stain: positive for 
candida 
Oral Candidiasis 150 
9 Josephine 32/F Neck 
swelling, 
hard of 
Multiple nodes in level III 
firm mobile sensorineural 
hearing loss by TFT 
FNAC: Non specific 
lymphadenitis,PTA: Bilateral 
moderate sensorineural 
Non specific 
cervical 
lymphadenopathy 
200 
hearing hearing loss with SN hearing 
loss 
 
10 Mary 39/F Oral white 
patches, 
hard of 
hearing 
Oral white patches on 
tongue on scraping leaves 
red raw surface, SN loss 
by TFT 
PTA: bilateral mild SN 
hearing loss Gram stain: 
positive for candida 
Oral Candidiasis 
with SN hearing 
loss 
300 
11 Ahmed 44/M Oral painful 
ulcers 
Multiple ulcers on lips Tzanck smear:positive Oral Herpes 
simplex 
300 
12 Raman 49/M Hoarseness 
of 
voice,ATT 
completed 1 
year back 
IDL: mouse nibbled 
appearance of both vocal 
cords on medial surface 
ant 2/3rd whitish keratotic 
lesions on the right vocal 
cord posteriorly 
Sputum AFB: negative 
CXR: old healed PT on apex 
of right lobe of lung biopsy of 
laryngeal lesion: TB laryngitis 
ATT completed 2 years back 
TB Laryngitis 240 
13 Mariappan 50/M Left Ear 
discharge, 
Oral white 
patches 
Left CP, Oral white 
patches on scraping 
bleeds 
Pus C/S: Proteus, 
Staph.sensitive to amikacin, 
ciproflox, Gram stain: positive 
for candida 
Left CSOM with 
Oral Candidiasis 
340 
14 Sambandham 38/M Oral white 
patches 
Nasal 
Obstruction 
Curdy white patches on 
tongue bleeds on scraping, 
Nasal polyps 
DNE:Nasal polyps on right 
side fungal stain + for 
aspergillus, Gram stain: 
positive for candida 
Oral candidiasis 
with fungal 
sinusitis 
130 
15 Karuppannan 40/M Swellings 
on left side 
of neck 
Multiple nodes Level III, 
firm mobile matted  
FNAC:TB lymphadenitis 
SputumAFB: negativeCXR: 
old healed PT ATT completed  
TB lymphadenitis 150 
16 Murali 39/M Oral painful 
ulcers, 
headache 
Multiple ulcers on lips. 
DSL with pus in middle 
meatus 
DNE:Pus in middle meatus on 
left side Pus C/S: proteus 
sensitive to ciproflox Tzanck 
smear:CT PNS:bilateral 
maxillary and ethmoid 
sinusitis 
Oral Herpes 
simplex with 
Chronic Bacterial 
Sinusitis 
250 
17 Kousalya 37/F Oral white 
patches with 
hard of 
hearing 
Curdy white patches on 
buccal mucosa, SN loss 
on TFT 
PTA: bilateral mild SN 
hearing loss, Gram stain: 
positive for candida 
Oral Candidiasis 
with SN hearing 
loss 
150 
18 Nageesa 
begum 
23/F Swellings 
on right side 
of neck, 
hard of 
hearing 
Multiple matted nodes on 
right side level II and III, 
SN loss on TFT 
FNAC: TB Sputum AFB: 
positive,CXR: normal 
lymphadenitis, PTA: bilateral 
mild SN hearing loss ATT 
completed 1 year back 
TB lymphadenitis 
with SN hearing 
loss 
400 
19 Palani 42/M Oral white 
patches 
White patches on tongue 
bleeds on scraping 
Gram stain: positive for 
candida 
Oral Candidiasis 50 
20 Gangadhar 36/M Hoarseness 
of voice, 
ATT 
completed 2 
years back 
IDL: mouse nibbled 
appearance of both vocal 
cords in ant 1/3rd whitish 
keratotic lesions on 
anterior commissure 
Sputum AFB: negative, CXR: 
Normal biopsy of laryngeal 
lesion: TB laryngitis ATT 
completed 6 months back  
TB Laryngitis 220 
21 Venkatesan 50/M White 
patches in 
mouth,neck 
swelling 
Whitish horny plaques on 
lateral side of tongue 
which cannot be 
removed,single lymph 
node level II on left side 
firm mobile 
FNAC  of lymph node: non 
specific chronic 
lymphadenitis,Gram stain: 
negative for candida, biopsy 
consistent with hairy 
leukoplakia 
Oral Hairy 
leukoplakia, non 
specific cervical 
lymphadenitis 
50 
22 Ravi 34/M White 
patches on 
tongue 
White patches on tongue, 
bleeds when removed 
Gram stain: positive for 
candida 
Oral candidiasis 100 
23 Venu 43/M Hard of 
hearing, 
neck 
swelling 
TFT: bilateral SN hearing 
loss, multiple neck nodes 
level III on left side 
PTA: bilateral mild SN 
hearing loss,FNAC: chronic 
nonspecific lymphadenitis 
Non specific 
cervical 
lymphadenitis, 
bilateral SN 
hearing loss 
340 
24 Boopathy 33/M White 
patces in 
mouth  
White patches on buccal 
mucosa,bleeds on removal 
Gram stain: positive for 
candida 
Oral candidiasis 290 
25 vijay 34/M Painful 
ulcers on 
lips 
Multiple small ulcers on 
lips on both outer and 
inner surfaces 
Tzanck smear:positive Oral Herpes 
simplex 
390 
26 Kotteswaran 35/M Right ear 
discharge, 
neck 
swelling 
Multiple lymph nodes in 
level III with right CP 
FNAC: non specific 
lymphadenitis, pus right ear 
C/S proteus pnemococcus 
sensitive to amikacin, oflox 
Non specific 
cervical 
lymphadenitis, 
right CSOM with 
CP 
320 
27 Azad 42/M Painful 
ulcers on 
lips 
Multiple ulcers on inner 
surface of lips 
Tzanck smear: positive Oral herpes 
simplex 
230 
28 Vasanth 38/M White 
patches on 
tongue, 
headache 
White patches on tongue 
bleeds on removal, DSL  
Gram stain: positive for 
candida, DNE: pus in middle 
meatus on left side Pus C/S: 
H.influenza, 
strept.pneumoniaeCT PNS: 
left maxillary sinusitis 
Oral candidiasis. 
Chronic maxillary 
sinusitis on left 
side 
300 
29 Maheswaran 33/M White 
patches in 
mouth  
White patches on buccal 
mucosa which bleed on 
touch 
Gram stain: positive for 
candida 
Oral candidiasis 300 
 
 
 
 
 
30 Sultan 45/M Neck 
swelling on 
both sides 
Multiple nodes on both 
sides levels II,III, firm 
mobile 
FNAC: nonspecific chronic 
inflammatory reaction 
Chronic non 
specific cervical 
lymphadenopathy 
220 
31 Eswari 30/F Neck 
swelling on 
right side 
Two nodes palpable on 
right side level III, firm 
mobile 
FNAC: chronic non specific 
lymphadenitis 
Chronic non 
specific 
lymphadenopathy 
330 
32 Balakrishnan 39/M Headache. 
Nasal 
obstruction. 
Hoarseness 
of voice 
DSR,IDL:whitsh 
exophytic lesions on both 
vocal cords ant 2/3rd 
DNE: pus in middle meatus 
on right side, CT PNS: right 
maxillary and ethmoid 
sinusitis.biopsy of laryngeal 
lesion: TB laryngitis. Pus C/S; 
pnemococcus sensitive to 
cefotaxime, oflox Sputum 
AFB: positive, CXR: PT, on 
ATT now 1 month course 
completed 
Chronic bacterial 
sinusitis, TB 
laryngitis 
200 
33 Sumathy 35/F White 
patches in 
mouth 
White patches on tongue 
and buccal mucosa which 
bleeds on removal 
Gram stain: positive for 
candida 
Oral candidiasis 100 
34 Banumathy 30/F Hard of 
hearing, 
neck 
TFT: bilateral SN hearing 
loss.multiple lymph nodes 
on right side level V firm 
PTA: bilateral mild SN 
hearing loss.FNAC: chronic 
reactive hyperplasia 
SN hearing loss, 
chronic nonspecific 
cervical 
120 
swelling mobile lymphadenopathy 
35 Visveswaran 42/F Painful oral 
ulcers 
Multiple ulcers on lips 
and tongue 
Tzanck smear: positive Oral Herpes 
simplex 
220 
36 Ramasamy 35/M White 
patches on 
tongue, 
neck 
swelling 
Multiple nodes on left 
side level V, white 
patches on tongue which 
bleeds on removal 
FNAC: chronic reactive 
hyperplasia, Gram 
stain:positive for candida 
Oral candidiasis 
with chronic non 
specific cervical 
lymphadenopathy 
230 
37 Rengan 39/M Swelling in 
mouth 
Fleshy popular swelling 
on hard palate on left side 
Biopsy: consistent with 
kaposi’s sarcoma 
Kaposi’s sarcoma 50 
38 Soundararajan 28/M Hoarseness 
of voice, on 
ATT 
Whitish keratotic lesions 
on both vocal cords ant 
1/3rd 
Biopsy: TB laryngitis Sputum 
AFB:negative,  ATT 
completed 4 months  CXR: 
old healed PT 
TB  laryngitis 220 
39 Govindan 42/M Hard of 
hearing, 
neck 
swelling 
TFT: bilateral SN loss, 
multiple nodes on left side 
level V 
PTA: bilateral mild SN 
hearing loss, FNAC: chronic 
nonspecific inflammatory 
reaction 
SN hearing loss 
with chronic 
nonspecific 
cervical 
lymphadenopathy 
300 
40 Tara 32/F Painful 
ulcers on 
lips 
Multiple ulcers on lips 
and tongue 
Tzanck smear: positive Oral herpes 
simplex 
200 
41 Mohan 30/M White 
patches in 
mouth hard 
of hearing 
White patches on buccal 
mucosa which bleeds on 
removal, TFT: bilateral 
SN hearing loss 
Gram stain: positive for 
candida, PTA: bilateral 
moderate SN hearing loss 
Oral candidiasis 
with SN hearing 
loss 
110 
42 Sendhil 35/M White 
patches in 
mouth 
White horny plaque on 
lateral borders of tongue 
which cannot be removed 
Gram stain: negative for 
candida biopsy consistent with 
hairy leukoplakia 
Oral hairy 
leukoplakia 
120 
43 Sundari 30/F Oral painful 
ulcers 
Multiple ulcers on lips, 
tongue 
Tzanck smear: positive Oral herpes 
simplex 
220 
44 Valliyammal 22/F Neck 
swelling 
Multiple nodes on left 
side level III firm mobile 
FNAC: chronic reactive 
hyperplasia 
Chronic 
nonspecific 
lymphadenopathy 
 
 
200 
45 Buvana 35/F Oral white 
patches 
White patches on tongue 
which bleeds on removal 
Gram stain:positive for 
candida 
Oral candidiasis 50 
46 Mahadevi 40/F Oral painful 
ulcers 
Multiple ulcers on lips Tzanck smear positive Oral herpes 
simplex 
290 
47 Banu 25/F Oral white 
patches, 
hard of 
hearing 
White patches on tongue 
which bleeds on 
removal,TFT: bilateral 
mild SN hearing loss 
Gram stain: positive for 
candida, TFT: bilateral mild 
SN hearing loss 
Oral candidiasis, 
bilateral SN 
hearing loss 
250 
48 Arun 38/M Neck 
swelling 
Multiple nodes on left 
side level V 
FNAC:Chronic nonspecific 
inflammatory reaction 
Chronic 
nonspecific 
cervical 
lymphadenopathy 
340 
49 Manohar 35/M Oral white 
patches 
White patches on tongue 
which bleeds on removal 
Gram stain: positive for 
candida 
Oral candidiasis 80 
50 Loganathan 38/M Oral white 
patches 
White patches on buccal 
mucosa which bleeds on 
touch 
Gram stain: positive for 
candida 
Oral candidiasis 280 
 
